Anhui Anke Biotechnology (Group) Co., Ltd. (300009.SZ) Stock Price, Financials & Summary | drillr

Skip to content

Sign in Sign up

Price chart

Aug 20Aug 25Aug 28Sep 2Sep 7Sep 10Sep 15Sep 18

Key dataSep 18, 2026

OpenCNY 8.10

From 52W high−24.40%

Volume18.11M

Market capCNY 14.18B

P/E (TTM)19.3x

P/S (TTM)5.3x

Div yield3.06%

Key dataSep 18, 2026

Open

CNY 8.10

From 52W high

−24.40%

Volume

18.11M

Market cap

CNY 14.18B

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

14.3x

P/E (TTM)

19.3x

RSI (14)

45.9

MomentumView details →

1D Return

−5.35%

YTD Return

−14.73%

ValuationView details →

P/E (Fwd)

—

P/E (TTM)

19.3x

EV/EBITDA

14.3x

EV/Sales

5.3x

P/S (TTM)

5.3x

P/B (TTM)

3.3x

ProfitabilityView details →

Gross Margin

75.37%

Net Margin

27.11%

EBITDA Margin

37.33%

ROE (TTM)

14.63%

ROA (TTM)

12.25%

Asset Turnover

0.46x

GrowthView details →

Revenue YoY

+2.02%

EPS YoY

+0.81%

FCF YoY

+5.80%

Revenue CAGR 3Y

+4.32%

EPS CAGR 3Y

+0.77%

EBITDA YoY

—

MomentumView details →

1D Return

−5.35%

YTD Return

−14.73%

1Y Return

−20.85%

RSI (14)

45.9

vs 50D SMA

−3.23%

vs 200D SMA

−10.07%

Capital & dividendView details →

Debt/Equity

0.00x

Current Ratio

4.30x

Quick Ratio

3.83x

Div Yield

3.06%

Div Rate

CNY 0.25

Div Growth 1Y

+0.00%

EarningsView details →

EPS (Actual)

CNY 0.10

EPS Surprise

—

Beats (12Q)

—

Next Q EPS Est

—

Avg Surprise (4Q)

—

Rev Surprise

—

Financials snapshotView financials →

Revenue (TTM)

2.56B

Net Income (TTM)

693.78M

Op. CF (TTM)

808.82M

Next earningsOct 23, 2026 →

Latest newsMore news →

Anke Bio and Shenshi Technology signed a strategic cooperation agreement to collaborate on AI4S-enabled design and optimization of ADC payload molecules for innovative drug development.3d ago

Anke Bio and DP Technology signed a strategic cooperation agreement to collaborate on AI-driven molecular design and optimization of antibody-drug conjugate payloads.4d ago

Similar companies

双欣材料001369.SZ 晶瑞电材300655.SZ 康泰生物300601.SZ 广生堂300436.SZ 海川智能300720.SZ 华宏科技002645.SZ Find similar companies →

Latest newsMore news →

Anke Bio and Shenshi Technology signed a strategic cooperation agreement to collaborate on AI4S-enabled design and optimization of ADC payload molecules for innovative drug development.3d ago Anke Bio and DP Technology signed a strategic cooperation agreement to collaborate on AI-driven molecular design and optimization of antibody-drug conjugate payloads.4d ago Anke Bio's PA3-17, the world's first autologous CD7-CAR-T cell therapy, entered China's breakthrough therapy designation and is expected to complete pivotal Phase II trials in September and industrialize globally by end-2027.5d ago